Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China
· Delayed Price · Currency is CNY 5.03
+0.07 (1.41%)
May 20, 2025, 2:45 PM CST
SHE:300289 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 320.61 | 336.32 | 421.98 | 675.94 | 540.94 | 449.59 | Upgrade
|
| Other Revenue | 33.91 | 33.91 | 39.57 | 30.04 | 23.12 | 21.92 | Upgrade
|
| Revenue | 354.51 | 370.23 | 461.55 | 705.98 | 564.06 | 471.51 | Upgrade
|
| Revenue Growth (YoY) | -20.87% | -19.79% | -34.62% | 25.16% | 19.63% | -8.47% | Upgrade
|
| Cost of Revenue | 178.82 | 186.35 | 198.01 | 407.77 | 269.78 | 215.87 | Upgrade
|
| Gross Profit | 175.7 | 183.88 | 263.55 | 298.2 | 294.28 | 255.64 | Upgrade
|
| Selling, General & Admin | 169.13 | 176.94 | 183.21 | 205.67 | 179.42 | 156.78 | Upgrade
|
| Research & Development | 30.71 | 32.95 | 36.87 | 34.96 | 32.75 | 38.47 | Upgrade
|
| Other Operating Expenses | 11.18 | 10.67 | 11.79 | 12.65 | 11.07 | 6.61 | Upgrade
|
| Operating Expenses | 211.01 | 219.7 | 243.53 | 280.27 | 227.66 | 276.48 | Upgrade
|
| Operating Income | -35.32 | -35.83 | 20.02 | 17.94 | 66.62 | -20.84 | Upgrade
|
| Interest Expense | -0.25 | -0.3 | -0.65 | -1.29 | -2.15 | -2.56 | Upgrade
|
| Interest & Investment Income | 15.59 | 17.28 | 17.22 | 18.86 | 8 | 7.88 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.38 | -0.38 | -0.81 | -0.75 | 1.2 | -1.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.33 | -0.75 | -0.35 | -0.65 | -0.65 | -1.15 | Upgrade
|
| EBT Excluding Unusual Items | -21.69 | -19.98 | 35.42 | 34.11 | 73.01 | -17.79 | Upgrade
|
| Impairment of Goodwill | -71.13 | -71.13 | -14.88 | -30.53 | -20.41 | -1.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | 15.6 | 14.33 | -1.85 | 1.99 | 3.47 | 8.26 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | 0.45 | 1.34 | -0.93 | Upgrade
|
| Asset Writedown | 0.08 | -0.02 | -0.22 | -0.16 | -1.3 | -0.08 | Upgrade
|
| Legal Settlements | -0.06 | -0.06 | - | -32.6 | - | - | Upgrade
|
| Other Unusual Items | 3.85 | 3.67 | 6.07 | 1.57 | 2.69 | -2.44 | Upgrade
|
| Pretax Income | -73.33 | -73.18 | 24.53 | -25.16 | 58.8 | -14.79 | Upgrade
|
| Income Tax Expense | -0.17 | 1.03 | 1.87 | 10.87 | 11.62 | 14.63 | Upgrade
|
| Earnings From Continuing Operations | -73.16 | -74.21 | 22.66 | -36.03 | 47.18 | -29.42 | Upgrade
|
| Minority Interest in Earnings | -0.48 | -0.89 | -7.32 | -20.24 | -24.76 | -21.56 | Upgrade
|
| Net Income | -73.65 | -75.1 | 15.34 | -56.27 | 22.42 | -50.98 | Upgrade
|
| Net Income to Common | -73.65 | -75.1 | 15.34 | -56.27 | 22.42 | -50.98 | Upgrade
|
| Shares Outstanding (Basic) | 545 | 544 | 544 | 563 | 448 | 425 | Upgrade
|
| Shares Outstanding (Diluted) | 545 | 544 | 544 | 563 | 448 | 425 | Upgrade
|
| Shares Change (YoY) | 0.19% | -0.01% | -3.35% | 25.50% | 5.54% | 34.68% | Upgrade
|
| EPS (Basic) | -0.14 | -0.14 | 0.03 | -0.10 | 0.05 | -0.12 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.14 | 0.03 | -0.10 | 0.05 | -0.12 | Upgrade
|
| Free Cash Flow | 51.87 | 33.18 | 112.11 | 69.81 | 74.56 | 107.17 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.06 | 0.21 | 0.12 | 0.17 | 0.25 | Upgrade
|
| Dividend Per Share | - | - | 0.010 | - | 0.020 | - | Upgrade
|
| Gross Margin | 49.56% | 49.67% | 57.10% | 42.24% | 52.17% | 54.22% | Upgrade
|
| Operating Margin | -9.96% | -9.68% | 4.34% | 2.54% | 11.81% | -4.42% | Upgrade
|
| Profit Margin | -20.77% | -20.29% | 3.32% | -7.97% | 3.98% | -10.81% | Upgrade
|
| Free Cash Flow Margin | 14.63% | 8.96% | 24.29% | 9.89% | 13.22% | 22.73% | Upgrade
|
| EBITDA | 18.04 | 18.67 | 79.05 | 76.87 | 122.16 | 31.33 | Upgrade
|
| EBITDA Margin | 5.09% | 5.04% | 17.13% | 10.89% | 21.66% | 6.64% | Upgrade
|
| D&A For EBITDA | 53.36 | 54.5 | 59.03 | 58.93 | 55.54 | 52.17 | Upgrade
|
| EBIT | -35.32 | -35.83 | 20.02 | 17.94 | 66.62 | -20.84 | Upgrade
|
| EBIT Margin | -9.96% | -9.68% | 4.34% | 2.54% | 11.81% | -4.42% | Upgrade
|
| Effective Tax Rate | - | - | 7.63% | - | 19.76% | - | Upgrade
|
| Revenue as Reported | 354.51 | 370.23 | 461.55 | 705.98 | 564.06 | 471.51 | Upgrade
|
| Advertising Expenses | - | 1.01 | 2.14 | 2.82 | 2.27 | 2.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.